시장조사 보고서 : 세계의 메스꺼움 및 구토 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Nausea And Vomiting Treatment Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02106 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 97 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 메스꺼움 및 구토 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (세로토닌 수용체 길항약, 뉴로키닌 NK1 수용체 길항약, 기타)와 용도별 시장규모 (CINV, PONV, 멀미, 임신, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 메스꺼움 및 구토 치료 시장 점유율
- 지역별 메스꺼움 및 구토 치료 시장규모
- 주요지역의 종류별 시장규모 (세로토닌 수용체 길항약, 뉴로키닌 NK1 수용체 길항약, 기타)
- 주요지역의 용도별 시장규모 (CINV, PONV, 멀미, 임신, 기타)
- 미주의 메스꺼움 및 구토 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 메스꺼움 및 구토 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 메스꺼움 및 구토 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 메스꺼움 및 구토 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 메스꺼움 및 구토 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Nausea And Vomiting Treatment will have significant change from previous year. By the most conservative estimates of global Nausea And Vomiting Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4777.1 million in 2020. Over the next five years the Nausea And Vomiting Treatment market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 6201.9 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Nausea And Vomiting Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others
Serotonin receptor antagonist had the biggest market share of 61% in 2018.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
CINV
PONV
Motion Sickness
Pregnancy
Others
CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Atnahs Pharma UK Limited
Mylan
Duchesnay
Tesaro

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nausea And Vomiting Treatment Market Size 2016-2026
2.1.2 Nausea And Vomiting Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Nausea And Vomiting Treatment Segment by Type
2.2.1 Serotonin Receptor Antagonist
2.2.2 Serotonin Receptor Antagonist
2.2.3 Others
2.3 Nausea And Vomiting Treatment Market Size by Type
2.3.1 Global Nausea And Vomiting Treatment Market Size CAGR by Type
2.3.2 Global Nausea And Vomiting Treatment Market Size Market Share by Type (2016-2021)
2.4 Nausea And Vomiting Treatment Segment by Application
2.4.1 CINV
2.4.2 PONV
2.4.3 Motion Sickness
2.4.4 Pregnancy
2.4.5 Others
2.5 Nausea And Vomiting Treatment Market Size by Application
2.5.1 Global Nausea And Vomiting Treatment Market Size CAGR by Application
2.5.2 Global Nausea And Vomiting Treatment Market Size Market Share by Application (2016-2021)

3 Nausea And Vomiting Treatment Market Size by Players
3.1 Nausea And Vomiting Treatment Market Size Market Share by Players
3.1.1 Global Nausea And Vomiting Treatment Revenue by Players (2019-2021E)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Nausea And Vomiting Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Nausea And Vomiting Treatment by Regions
4.1 Nausea And Vomiting Treatment Market Size by Regions (2016-2021)
4.2 Americas Nausea And Vomiting Treatment Market Size Growth (2016-2021)
4.3 APAC Nausea And Vomiting Treatment Market Size Growth (2016-2021)
4.4 Europe Nausea And Vomiting Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Nausea And Vomiting Treatment Market Size Growth (2016-2021)

5 Americas
5.1 Americas Nausea And Vomiting Treatment Market Size by Country (2016-2021)
5.2 Americas Nausea And Vomiting Treatment Market Size by Type (2016-2021)
5.3 Americas Nausea And Vomiting Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Nausea And Vomiting Treatment Market Size by Region (2016-2021)
6.2 APAC Nausea And Vomiting Treatment Market Size by Type (2016-2021)
6.3 APAC Nausea And Vomiting Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Nausea And Vomiting Treatment by Country (2016-2021)
7.2 Europe Nausea And Vomiting Treatment Market Size by Type (2016-2021)
7.3 Europe Nausea And Vomiting Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Nausea And Vomiting Treatment by Region (2016-2021)
8.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Nausea And Vomiting Treatment Market Forecast
10.1 Global Nausea And Vomiting Treatment Forecast by Regions (2021-2026)
10.1.1 Global Nausea And Vomiting Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Nausea And Vomiting Treatment Forecast
10.1.3 APAC Nausea And Vomiting Treatment Forecast
10.1.4 Europe Nausea And Vomiting Treatment Forecast
10.1.5 Middle East & Africa Nausea And Vomiting Treatment Forecast
10.2 Americas Nausea And Vomiting Treatment Forecast by Countries (2021-2026)
10.2.1 United States Nausea And Vomiting Treatment Market Forecast
10.2.2 Canada Nausea And Vomiting Treatment Market Forecast
10.2.3 Mexico Nausea And Vomiting Treatment Market Forecast
10.2.4 Brazil Nausea And Vomiting Treatment Market Forecast
10.3 APAC Nausea And Vomiting Treatment Forecast by Region (2021-2026)
10.3.1 China Nausea And Vomiting Treatment Market Forecast
10.3.2 Japan Nausea And Vomiting Treatment Market Forecast
10.3.3 Korea Nausea And Vomiting Treatment Market Forecast
10.3.4 Southeast Asia Nausea And Vomiting Treatment Market Forecast
10.3.5 India Nausea And Vomiting Treatment Market Forecast
10.3.6 Australia Nausea And Vomiting Treatment Market Forecast
10.4 Europe Nausea And Vomiting Treatment Forecast by Country (2021-2026)
10.4.1 Germany Nausea And Vomiting Treatment Market Forecast
10.4.2 France Nausea And Vomiting Treatment Market Forecast
10.4.3 UK Nausea And Vomiting Treatment Market Forecast
10.4.4 Italy Nausea And Vomiting Treatment Market Forecast
10.4.5 Russia Nausea And Vomiting Treatment Market Forecast
10.5 Middle East & Africa Nausea And Vomiting Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Nausea And Vomiting Treatment Market Forecast
10.5.2 South Africa Nausea And Vomiting Treatment Market Forecast
10.5.3 Israel Nausea And Vomiting Treatment Market Forecast
10.5.4 Turkey Nausea And Vomiting Treatment Market Forecast
10.5.5 GCC Countries Nausea And Vomiting Treatment Market Forecast
10.6 Global Nausea And Vomiting Treatment Forecast by Type (2021-2026)
10.7 Global Nausea And Vomiting Treatment Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Information
11.1.2 Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Merck & Co. Inc. Main Business Overview
11.1.5 Merck & Co. Inc. Latest Developments
11.2 Helsinn Group
11.2.1 Helsinn Group Company Information
11.2.2 Helsinn Group Nausea And Vomiting Treatment Product Offered
11.2.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Helsinn Group Main Business Overview
11.2.5 Helsinn Group Latest Developments
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Information
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Main Business Overview
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Information
11.4.2 Kyowa Kirin Nausea And Vomiting Treatment Product Offered
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Kyowa Kirin Main Business Overview
11.4.5 Kyowa Kirin Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Nausea And Vomiting Treatment Product Offered
11.5.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Information
11.6.2 Qilu Pharma Nausea And Vomiting Treatment Product Offered
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Qilu Pharma Main Business Overview
11.6.5 Qilu Pharma Latest Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Information
11.7.2 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.8 Taiji group
11.8.1 Taiji group Company Information
11.8.2 Taiji group Nausea And Vomiting Treatment Product Offered
11.8.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Taiji group Main Business Overview
11.8.5 Taiji group Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Nausea And Vomiting Treatment Product Offered
11.9.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Information
11.10.2 Heron Therapeutics Nausea And Vomiting Treatment Product Offered
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Heron Therapeutics Main Business Overview
11.10.5 Heron Therapeutics Latest Developments
11. Atnahs Pharma UK Limited
11.11.1 Atnahs Pharma UK Limited Company Information
11.11.2 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Offered
11.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Atnahs Pharma UK Limited Main Business Overview
11.11.5 Atnahs Pharma UK Limited Latest Developments
11.12 Mylan
11.12.1 Mylan Company Information
11.12.2 Mylan Nausea And Vomiting Treatment Product Offered
11.12.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Mylan Main Business Overview
11.12.5 Mylan Latest Developments
11.13 Duchesnay
11.13.1 Duchesnay Company Information
11.13.2 Duchesnay Nausea And Vomiting Treatment Product Offered
11.13.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Duchesnay Main Business Overview
11.13.5 Duchesnay Latest Developments
11.14 Tesaro
11.14.1 Tesaro Company Information
11.14.2 Tesaro Nausea And Vomiting Treatment Product Offered
11.14.3 Tesaro Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Tesaro Main Business Overview
11.14.5 Tesaro Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Nausea And Vomiting Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Serotonin Receptor Antagonist
Table 3. Major Players of Neurokinin NK1 Receptor Antagonist
Table 4. Major Players of Others
Table 5. Nausea And Vomiting Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Nausea And Vomiting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Nausea And Vomiting Treatment Market Size Market Share by Type (2016-2021)
Table 8. Nausea And Vomiting Treatment Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Nausea And Vomiting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Nausea And Vomiting Treatment Market Size Market Share by Application (2016-2021)
Table 11. Global Nausea And Vomiting Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Nausea And Vomiting Treatment Revenue Market Share by Players (2019-2021E)
Table 13. Nausea And Vomiting Treatment Key Players Head office and Products Offered
Table 14. Nausea And Vomiting Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nausea And Vomiting Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Nausea And Vomiting Treatment Market Size Market Share by Regions 2016-2021
Table 19. Americas Nausea And Vomiting Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Nausea And Vomiting Treatment Market Size Market Share by Country (2016-2021)
Table 21. Americas Nausea And Vomiting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Nausea And Vomiting Treatment Market Size Market Share by Type (2016-2021)
Table 23. Americas Nausea And Vomiting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Nausea And Vomiting Treatment Market Size Market Share by Application (2016-2021)
Table 25. APAC Nausea And Vomiting Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Nausea And Vomiting Treatment Market Size Market Share by Region (2016-2021)
Table 27. APAC Nausea And Vomiting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Nausea And Vomiting Treatment Market Size Market Share by Type (2016-2021)
Table 29. APAC Nausea And Vomiting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Nausea And Vomiting Treatment Market Size Market Share by Application (2016-2021)
Table 31. Europe Nausea And Vomiting Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Nausea And Vomiting Treatment Market Size Market Share by Country (2016-2021)
Table 33. Europe Nausea And Vomiting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Nausea And Vomiting Treatment Market Size Market Share by Type (2016-2021)
Table 35. Europe Nausea And Vomiting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Nausea And Vomiting Treatment Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Nausea And Vomiting Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Nausea And Vomiting Treatment
Table 44. Key Application and Potential Industries of Nausea And Vomiting Treatment
Table 45. Key Challenges of Nausea And Vomiting Treatment
Table 46. Key Trends of Nausea And Vomiting Treatment
Table 47. Global Nausea And Vomiting Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Nausea And Vomiting Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Nausea And Vomiting Treatment Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Application (2021-2026)
Table 53. Merck & Co. Inc. Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 54. Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered
Table 55. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Merck & Co. Inc. Main Business
Table 57. Merck & Co. Inc. Latest Developments
Table 58. Helsinn Group Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 59. Helsinn Group Nausea And Vomiting Treatment Product Offered
Table 60. Helsinn Group Main Business
Table 61. Helsinn Group Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Helsinn Group Latest Developments
Table 63. Unimed Pharmaceuticals (AbbVie Inc.) Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 64. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered
Table 65. Unimed Pharmaceuticals (AbbVie Inc.) Main Business
Table 66. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
Table 68. Kyowa Kirin Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 69. Kyowa Kirin Nausea And Vomiting Treatment Product Offered
Table 70. Kyowa Kirin Main Business
Table 71. Kyowa Kirin Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Kyowa Kirin Latest Developments
Table 73. Sanofi Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 74. Sanofi Nausea And Vomiting Treatment Product Offered
Table 75. Sanofi Main Business
Table 76. Sanofi Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Sanofi Latest Developments
Table 78. Qilu Pharma Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 79. Qilu Pharma Nausea And Vomiting Treatment Product Offered
Table 80. Qilu Pharma Main Business
Table 81. Qilu Pharma Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Qilu Pharma Latest Developments
Table 83. Teva Pharmaceutical Industries Ltd. Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 84. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered
Table 85. Teva Pharmaceutical Industries Ltd. Main Business
Table 86. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 88. Taiji group Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 89. Taiji group Nausea And Vomiting Treatment Product Offered
Table 90. Taiji group Main Business
Table 91. Taiji group Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Taiji group Latest Developments
Table 93. Novartis Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 94. Novartis Nausea And Vomiting Treatment Product Offered
Table 95. Novartis Main Business
Table 96. Novartis Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Novartis Latest Developments
Table 98. Heron Therapeutics Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 99. Heron Therapeutics Nausea And Vomiting Treatment Product Offered
Table 100. Heron Therapeutics Main Business
Table 101. Heron Therapeutics Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Heron Therapeutics Latest Developments
Table 103. Atnahs Pharma UK Limited Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 104. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Offered
Table 105. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Atnahs Pharma UK Limited Main Business
Table 107. Atnahs Pharma UK Limited Latest Developments
Table 108. Mylan Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 109. Mylan Nausea And Vomiting Treatment Product Offered
Table 110. Mylan Main Business
Table 111. Mylan Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Mylan Latest Developments
Table 113. Duchesnay Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 114. Duchesnay Nausea And Vomiting Treatment Product Offered
Table 115. Duchesnay Main Business
Table 116. Duchesnay Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Duchesnay Latest Developments
Table 118. Tesaro Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 119. Tesaro Nausea And Vomiting Treatment Product Offered
Table 120. Tesaro Main Business
Table 121. Tesaro Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 122. Tesaro Latest Developments
List of Figures
Figure 1. Nausea And Vomiting Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nausea And Vomiting Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Nausea And Vomiting Treatment Market Size Market Share by Type in 2020
Figure 7. Nausea And Vomiting Treatment in CINV
Figure 8. Global Nausea And Vomiting Treatment Market: CINV (2016-2021) & ($ Millions)
Figure 9. Nausea And Vomiting Treatment in PONV
Figure 10. Global Nausea And Vomiting Treatment Market: PONV (2016-2021) & ($ Millions)
Figure 11. Nausea And Vomiting Treatment in Motion Sickness
Figure 12. Global Nausea And Vomiting Treatment Market: Motion Sickness (2016-2021) & ($ Millions)
Figure 13. Nausea And Vomiting Treatment in Pregnancy
Figure 14. Global Nausea And Vomiting Treatment Market: Pregnancy (2016-2021) & ($ Millions)
Figure 15. Nausea And Vomiting Treatment in Others
Figure 16. Global Nausea And Vomiting Treatment Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Nausea And Vomiting Treatment Market Size Market Share by Application in 2020
Figure 18. Global Nausea And Vomiting Treatment Revenue Market Share by Player in 2020
Figure 19. Global Nausea And Vomiting Treatment Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Nausea And Vomiting Treatment Market Size 2016-2021 ($ Millions)
Figure 21. APAC Nausea And Vomiting Treatment Market Size 2016-2021 ($ Millions)
Figure 22. Europe Nausea And Vomiting Treatment Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Nausea And Vomiting Treatment Market Size 2016-2021 ($ Millions)
Figure 24. Americas Nausea And Vomiting Treatment Market Size Market Share by Country in 2020
Figure 25. Americas Nausea And Vomiting Treatment Market Size Market Share by Type in 2020
Figure 26. Americas Nausea And Vomiting Treatment Market Size Market Share by Application in 2020
Figure 27. United States Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Nausea And Vomiting Treatment Market Size Market Share by Regions in 2020
Figure 31. APAC Nausea And Vomiting Treatment Market Size Market Share by Type in 2020
Figure 32. APAC Nausea And Vomiting Treatment Market Size Market Share by Application in 2020
Figure 33. China Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Nausea And Vomiting Treatment Market Size Market Share by Country in 2020
Figure 40. Europe Nausea And Vomiting Treatment Market Size Market Share by Type in 2020
Figure 41. Europe Nausea And Vomiting Treatment Market Size Market Share by Application in 2020
Figure 42. Germany Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Application in 2020
Figure 50. Egypt Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Nausea And Vomiting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 56. APAC Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 57. Europe Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 59. United States Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 60. Canada Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 63. China Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 64. Japan Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 65. Korea Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 67. India Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Australia Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 69. Germany Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 70. France Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 71. UK Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 72. Italy Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 73. Russia Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 74. Spain Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 77. Israel Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)
Figure 79. GCC Country Nausea And Vomiting Treatment Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 메스꺼움 및 구토 치료 시장예측 2021년-2026년] (코드 : LPI-2201K02106) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 메스꺼움 및 구토 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 노안 치료 장치 시장예측 2021년-2026년
LPI-2201K02526 / LP Information / 2021년 12월 / 본 조사보고서는 노안 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Presbyopia Treatment Device will have significant change from previous year. By the most conservative estimates of global Presbyopia Treatment Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 고콜레스테롤혈증 치료 시장예측 2021년-2026년
LPI-2201K00141 / LP Information / 2021년 12월 / 본 조사보고서는 고콜레스테롤혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hypercholesterolemia Treatment will have significant change from previous year. By the most conservative estimates of global Hypercholesterolemia Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 과민성 방광 치료 시장예측 2021년-2026년
LPI-2201K02444 / LP Information / 2021년 12월 / 본 조사보고서는 과민성 방광 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Overactive Bladder Treatment will have significant change from previous year. By the most conservative estimates of global Overactive Bladder Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4901 million in...

세계의 신경 장애성 통증 치료 시장예측 2021년-2026년
LPI-2201K02241 / LP Information / 2021년 12월 / 본 조사보고서는 신경 장애성 통증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Neuropathy Pain Treatment will have significant change from previous year. By the most conservative estimates of global Neuropathy Pain Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 8078.4 million in...

세계의 시차 적응 치료 시장예측 2021년-2026년
LPI-2201K00080 / LP Information / 2021년 12월 / 본 조사보고서는 시차 적응 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Jet Lag Treatment will have significant change from previous year. By the most conservative estimates of global Jet Lag Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 420.5 million in...

세계의 녹내장 치료 시장예측 2021년-2026년
LPI-2201K00104 / LP Information / 2021년 12월 / 본 조사보고서는 녹내장 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Glaucoma Treatment will have significant change from previous year. By the most conservative estimates of global Glaucoma Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 저나트륨 혈증 치료 시장예측 2021년-2026년
LPI-2201K00145 / LP Information / 2021년 12월 / 본 조사보고서는 저나트륨 혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hyponatremia Treatment will have significant change from previous year. By the most conservative estimates of global Hyponatremia Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...